Research Directory

The case for optimism for Europe's biotech sector

Read more

Orchard Therapeutics targets rare diseases

Read more

The three waves of gene therapy

Read more

Building the next generation of gene transfer vectors

Read more

2017 Oncology Review: Global oncology drug approvals accelerate

Read more

2017 stock market review: Biotechs buoyed by share issues

Read more

Europe's biotech entrepreneurs

Read more

The case for value-based pricing

Read more

Bill Gates backs Alzheimer's disease research

Read more

The rise of single-arm studies in oncology

Read more